Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Colorcon
Teva
QuintilesIMS
Cantor Fitzgerald
Covington
Mallinckrodt
Moodys
Boehringer Ingelheim
Federal Trade Commission
Novartis

Generated: December 11, 2017

DrugPatentWatch Database Preview

METHIMAZOLE - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for methimazole and what is the scope of methimazole patent protection?

Methimazole
is the generic ingredient in two branded drugs marketed by Eci Pharms Llc, Heritage Pharma, Mylan, Rising Pharms Inc, Sandoz, Sun Pharm Inds Inc, King Pharms, and King Pharms Llc, and is included in nine NDAs. Additional information is available in the individual branded drug profile pages.

There are three drug master file entries for methimazole. Nineteen suppliers are listed for this compound.

Pharmacology for METHIMAZOLE

Medical Subject Heading (MeSH) Categories for METHIMAZOLE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Patent Submitted Product Substance Delist Req. Exclusivity Expiration
King PharmsTAPAZOLEmethimazoleTABLET;ORAL007517-004Approved Prior to Jan 1, 1982DISCNYesNo► Subscribe► Subscribe► Subscribe► Subscribe
Eci Pharms LlcMETHIMAZOLEmethimazoleTABLET;ORAL040547-001Feb 18, 2005ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Rising Pharms IncMETHIMAZOLEmethimazoleTABLET;ORAL202068-001Mar 7, 2012ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
King Pharms LlcTAPAZOLEmethimazoleTABLET;ORAL040320-001Mar 31, 2000ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
SandozMETHIMAZOLEmethimazoleTABLET;ORAL040411-002Mar 27, 2001ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Sun Pharm Inds IncMETHIMAZOLEmethimazoleTABLET;ORAL040870-002Sep 25, 2007ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
King Pharms LlcTAPAZOLEmethimazoleTABLET;ORAL040320-002Mar 31, 2000ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
MylanMETHIMAZOLEmethimazoleTABLET;ORAL040350-001Mar 29, 2000ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
King PharmsTAPAZOLEmethimazoleTABLET;ORAL007517-002Approved Prior to Jan 1, 1982DISCNYesNo► Subscribe► Subscribe► Subscribe► Subscribe
SandozMETHIMAZOLEmethimazoleTABLET;ORAL040411-001Mar 27, 2001ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

McKinsey
Mallinckrodt
Johnson and Johnson
Chinese Patent Office
Cantor Fitzgerald
Colorcon
Moodys
Accenture
Argus Health
Fuji

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot